Evidence review · standard

epitalon

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `epitalon`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/epitalon

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/epitalon/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/epitalon/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/epitalon/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/epitalon/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

Regeneration vs degeneration — where this fits

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

What it is

2025 study on human cell lines (normal and cancer) showing Epitalon extends telomeres dose-dependently via telomerase/hTERT in normal cells and ALT in cancer cells. 2026 narrative review discussing Epitalon in context of telomere biology and healthy aging interventions, based on searches through Jan 2026.

How it works

Step logic:

  1. 2026 review on peptides in orthopaedics, briefly covering epithalon for recovery and circadian regulation.
  2. 2025 research showing Epitalon improves bovine oocyte maturation, embryo development via telomerase activation.
  3. 2024 paper discussing AEDG (Epitalon) peptide neuroprotective effects in stem cell models.

Why it would work (logic chain)

  1. IF 2026 review on peptides in orthopaedics, briefly covering epithalon for recovery and circadian regulation. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  2. IF 2025 research showing Epitalon improves bovine oocyte maturation, embryo development via telomerase activation. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  3. IF 2024 paper discussing AEDG (Epitalon) peptide neuroprotective effects in stem cell models. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  4. IF 2025 study on human cell lines (normal and cancer) showing Epitalon extends telomeres dose-dependently via telomerase/hTERT in normal cells and ALT in cancer cells. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  5. IF 2026 narrative review discussing Epitalon in context of telomere biology and healthy aging interventions, based on searches through Jan 2026. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  6. IF 2025 review summarizing 25 years of Epitalon research showing geroprotective, antioxidant, neuroprotective effects via in vitro/in vivo studies; notes limited physico-chemical data. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).

How many people take it

There is no reliable global count of how many people take this compound. That number is not in this ledger.

What we can count from this ledger:

  • 0 anecdote source(s) (posts, threads, comments)
  • 0 anecdote-tier claim(s) derived from them

Logic: Without catalogued Reddit/X posts, this article cannot answer how many people take it — only what studies exist.

Evidence inventory

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 7
  • Claims tagged human evidence: 3
  • Claims tagged preclinical (animal/lab): 2
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 7

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.62 / 1.00 — moderate — human claims present in ledger

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties (source s1)

2025 review summarizing 25 years of Epitalon research showing geroprotective, antioxidant, neuroprotective effects via in vitro/in vivo studies; notes limited physico-chemical data.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity (source s2)

2025 study on human cell lines (normal and cancer) showing Epitalon extends telomeres dose-dependently via telomerase/hTERT in normal cells and ALT in cancer cells.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Therapeutic peptides in gerontology: mechanisms and applications for healthy aging (source s3)

2026 narrative review discussing Epitalon in context of telomere biology and healthy aging interventions, based on searches through Jan 2026.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions (source s4)

2026 review on peptides in orthopaedics, briefly covering epithalon for recovery and circadian regulation.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy (source s5)

2025 study on Epitalon (AEDG) antioxidant effects improving wound healing in diabetic retinopathy cell model.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Epitalon-activated telomerase enhance bovine oocyte maturation rate and post-thawed embryo development (source s6)

2025 research showing Epitalon improves bovine oocyte maturation, embryo development via telomerase activation.

Evidence type: Published research.

Short Peptides Protect Fibroblast-Derived Induced Pluripotent Stem Cell-Derived Neural Stem Cells from Amyloid-Beta Toxicity (source s7)

2024 paper discussing AEDG (Epitalon) peptide neuroprotective effects in stem cell models.

Evidence type: Published research.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Epitalon · peptide map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
Evidence · 7 sources · swipe →chain 1a9fbfd8f54a · verify chain · provenance
1 / 7
Evidence ledger 7 · tier-ranked · API
human
2025 study on human cell lines (normal and cancer) showing Epitalon extends telomeres dose-dependently via telomerase/hTERT in normal cells and ALT in cancer cells.
sources: s2
human
2026 narrative review discussing Epitalon in context of telomere biology and healthy aging interventions, based on searches through Jan 2026.
sources: s3
human
2026 review on peptides in orthopaedics, briefly covering epithalon for recovery and circadian regulation.
sources: s4
preclinical
2025 review summarizing 25 years of Epitalon research showing geroprotective, antioxidant, neuroprotective effects via in vitro/in vivo studies; notes limited physico-chemical data.
sources: s1
mechanistic
2025 research showing Epitalon improves bovine oocyte maturation, embryo development via telomerase activation.
sources: s6
2 more ranked claims
preclinical0.22low confidence
2025 study on Epitalon (AEDG) antioxidant effects improving wound healing in diabetic retinopathy cell model.
grok-4.3
Materialized from orphan source s5 by ledger repair
sources: s5
mechanistic0.22low confidence
2024 paper discussing AEDG (Epitalon) peptide neuroprotective effects in stem cell models.
grok-4.3
Materialized from orphan source s7 by ledger repair
sources: s7
Model swipes · 4 from 1 model · swipe →verify
1 / 4
grok-4.3writer
draft2026-06-29 16:50
epitalon
inspect — what it was prompted & output
prompted with
(default writer prompt)
1bccdea138b16015
grok-4.3source_hunt
sources2026-06-29 16:51
2 source(s) added · 2 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: epitalon
it output
3 source(s) added
ce920eaccf4afc7e
grok-4.3source_hunt
sources2026-06-29 16:51
2 source(s) added · 2 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: epitalon
it output
3 source(s) added
7a0939284e31a943
grok-4.3source_hunt
sources2026-06-29 16:51
3 source(s) added · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: epitalon
it output
3 source(s) added
8b66c75548e45e76
Ask this article · 8 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "2025 study on human cell lines (normal and cancer) showing Epitalon extends telomeres dose-dependently via telomerase/hTERT in normal cells …"?
ask epitalon claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "2026 narrative review discussing Epitalon in context of telomere biology and healthy aging interventions, based on searches through Jan 2026…"?
ask epitalon claim c3 · paste includes §SELF
What does the ledger say about this (human tier): "2026 review on peptides in orthopaedics, briefly covering epithalon for recovery and circadian regulation."?
ask epitalon claim c4 · paste includes §SELF
What does the ledger say about this (preclinical tier): "2025 review summarizing 25 years of Epitalon research showing geroprotective, antioxidant, neuroprotective effects via in vitro/in vivo stud…"?
ask epitalon claim c1 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "2025 research showing Epitalon improves bovine oocyte maturation, embryo development via telomerase activation."?
ask epitalon claim c6 · paste includes §SELF
What does the ledger say about this (preclinical tier): "2025 study on Epitalon (AEDG) antioxidant effects improving wound healing in diabetic retinopathy cell model."?
ask epitalon claim c5 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about epitalon — and what would you need me to tell you first?
ask epitalon condition gaps · paste includes §SELF
What good and bad outcomes are documented for epitalon (studies vs anecdotes)?
ask epitalon good bad experiences · paste includes §SELF
epitalon · posted 2026-06-29 · updated 2026-06-29 · 3 prior revisions
Ledger API & provenance
Provenance · 4 model passes · 0 tokens · $0 · 1 model
chain head b5c15e2ab7e7b54a
populate-init grok-4.3 · 2026-06-29 16:50 · 0 tok · b624e66be3e7
sources grok-4.3 · 2026-06-29 16:51 · 0 tok · f022674ab538
sources grok-4.3 · 2026-06-29 16:51 · 0 tok · 5c6a059561c1
sources grok-4.3 · 2026-06-29 16:51 · 0 tok · b5c15e2ab7e7
verify chain →
Live ledger · 2 payloads · 1 turn
recent activity · inspect
PIPELINE_SEED dispatch · 2026-06-20 22:28 · t_lqhkwxt9
PIPELINE_SEED dispatch · 2026-06-20 22:28 · t_lqhkwxt9
view full ledger & cards →
REST + ledger
read GET /api/articles/epitalon · GET /api/articles/epitalon?format=post (the editable body)
create/replace POST /api/articles/epitalon · PUT /api/articles/epitalon (replace, keeps revision) · PATCH /api/articles/epitalon (merge)
delete DELETE /api/articles/epitalon
writes need header x-terminal-key
LLM bundle GET /api/articles/epitalon/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim epitalon|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →